This program aims to develop a fully human monoclonal antibody against a novel immune checkpoint protein that enables T cell activation
The PATHWAY HER2 (4B5) test, the first and only FDA approved companion diagnostic for assessing HER2-low status since 2022, is now also approved to aid in the assessment of HER2-ultralow status for metastatic breast cancer patients.
Jemperli plus chemotherapy is the only immuno-oncology-based treatment to show statistically significant and clinically meaningful OS benefit in the overall population
Puri is an accomplished leader and financial sector veteran with over four decades of experience
The technical program will run in four sessions and a panel discussion on “Challenges in translation of medical technologies”
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
Harnessing advanced data analysis for early detection, prevention and better outcomes
Aster DM Healthcare and Quality Care India Limited have signed definitive agreements to merge, subject to regulatory, corporate and shareholders’ approvals
This strategic alliance is aimed at strengthening hospital systems and developing advanced AMR interventions
Subscribe To Our Newsletter & Stay Updated
_256_384.JPG)
